Cross-Border Private Equity into India: A 2025 Playbook for US GPs

US private-equity sponsors approaching India in 2025 face a market that is, by global standards, unusually well capitalised and unusually well governed. The flip side of that maturity is a narrower set of clean entry points, sharper valuation discipline, and a higher expectation of regulatory pre-clearance work before the first formal term sheet is exchanged.

Our advisory experience working with US sponsors across the past four quarters surfaces three structural decisions that disproportionately drive deal outcomes. The first is jurisdictional architecture. The choice between a direct India investment, a Singapore or Mauritius intermediate vehicle, or a US-side structuring layer is no longer a tax-only conversation. It is a governance and exit-mechanics conversation that should be settled before commercial terms are negotiated.

The second decision is governance posture. Indian promoter dynamics differ meaningfully from the operating-partner cultures US sponsors are accustomed to. Boards that work in India treat consent rights, reserved matters, and information rights as cooperative architecture rather than adversarial protection. Drafting that respects this distinction, while still preserving the sponsor's downside disciplines, is the most underappreciated source of deal friction.

The third is exit. Indian capital markets have absorbed an unprecedented IPO pipeline over the last eighteen months, but the dispersion of outcomes is wide. Sponsors should be modelling at least two exit paths from the outset, with documentation that supports both a structured secondary and a public-market exit without renegotiation of the original cap table.

Our practice frequently sits at the intersection of US sponsor counsel and Indian transactional execution. The mandates that close cleanly are the ones where that bridge is built before the first management presentation, not after the LOI.